Human Gene MIR762 (uc021tgs.1) Description and Page Index
  Description: Homo sapiens microRNA 762 (MIR762), microRNA.
RefSeq Summary (NR_031576): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage.
Transcript (Including UTRs)
   Position: hg19 chr16:30,905,224-30,905,306 Size: 83 Total Exon Count: 1 Strand: +


Page IndexSequence and LinksCTDRNA-Seq ExpressionMicroarray ExpressionOther Species
mRNA DescriptionsOther NamesModel InformationMethods
Data last updated: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr16:30,905,224-30,905,306)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTATable SchemaBioGPSEnsembl
Entrez GeneExonPrimerHGNCLynxPubMedStanford SOURCE

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 3.47 RPKM in Cervix - Ectocervix
Total median expression: 96.49 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  HZ408761 - JP 2015528002-A/1358: CHIRAL CONTROL.
HZ461117 - WO 2015190584-A/614: Kit or device and method for detecting prostate cancer.
HZ462381 - WO 2015190591-A/536: Kit and method for detecting breast cancer.
HZ463253 - WO 2015194535-A/347: Kit and method for detecting stomach cancer.
LG052095 - KR 1020150036642-A/1361: CHIRAL CONTROL.
LY499384 - KR 1020170018412-A/536: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY500066 - KR 1020170019425-A/347: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY500990 - KR 1020170016490-A/614: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ238833 - WO 2017171048-A/494: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS869909 - Sequence 614 from Patent EP3156483.
MS880699 - Sequence 536 from Patent EP3156498.
MS885185 - Sequence 347 from Patent EP3156503.
HI964779 - Sequence 64 from Patent WO2010139812.
HW060387 - JP 2012527478-A/51: Identification of MicroRNAs Involved in Post-Myocardial Infarction Remodeling and Heart Failure.
HW122349 - JP 2013504331-A/8: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
HW311950 - WO 2013125691-A/2: Method of Classification of Biological Fluid Test Sample.
HW340013 - JP 2013198483-A/2: Method of Classification of Biological Fluid Test Sample.
HW504988 - JP 2014502491-A/11: Plasma Cell Disorders.
HW799114 - WO 2014192907-A/220: Method for detecting miRNA used for differentiating disorders causing motor neuropathy.
HW823952 - JP 2015502176-A/13: Methods and Kits for Detecting Subjects at Risk of Having Cancer.
HW906801 - WO 2015037656-A/16: Autophagy-regulating microRNA.
HZ074566 - JP 2013535982-A/657: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ461085 - WO 2015190584-A/582: Kit or device and method for detecting prostate cancer.
HZ462106 - WO 2015190591-A/261: Kit and method for detecting breast cancer.
HZ463055 - WO 2015194535-A/149: Kit and method for detecting stomach cancer.
HZ466300 - JP 2015531594-A/3: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
HZ482586 - JP 2015535430-A/3092: TERMINALLY MODIFIED RNA.
HZ792517 - JP 2016504050-A/4262: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA400817 - Sequence 64 from Patent WO2011080318.
JA401795 - Sequence 64 from Patent WO2011080315.
JA402802 - Sequence 64 from Patent WO2011080316.
JA405433 - Sequence 64 from Patent EP2336353.
JA428959 - Sequence 64 from Patent WO2011095623.
JA885668 - Sequence 11 from Patent WO2012080721.
JB074994 - Sequence 254 from Patent WO2012168448.
JB233519 - Sequence 51 from Patent EP2437750.
JB249284 - Sequence 52 from Patent EP2478360.
JB620751 - Sequence 731 from Patent WO2013063544.
JC515249 - Sequence 5502 from Patent WO2014113089.
JE867437 - Sequence 244 from Patent WO2015128671.
LF160590 - JP 2016513950-A/656: Oligomers with improved off-target profile.
LF632662 - WO 2016117582-A/91: miRNA biomarkers for mental disorders.
LF644500 - JP 2016144439-A/91: Method for assessing cell aging.
LP951879 - Sequence 385 from Patent WO2017157650.
LQ072837 - Sequence 3161 from Patent EP2964234.
LQ441247 - Sequence 254 from Patent EP3029157.
LQ724757 - Sequence 390 from Patent WO2018096084.
LX154596 - JP 2017509333-A/244: Biomarkers for Endometriosis.
LX280721 - JP 2016105097-A/8: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
LY499109 - KR 1020170018412-A/261: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY499868 - KR 1020170019425-A/149: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY500958 - KR 1020170016490-A/582: PROSTATE CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ234339 - JP 2017181518-A/8: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
LZ238569 - WO 2017171048-A/230: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS833918 - Sequence 64 from Patent EP3112479.
MS869877 - Sequence 582 from Patent EP3156483.
MS880424 - Sequence 261 from Patent EP3156498.
MS884987 - Sequence 149 from Patent EP3156503.
MA646338 - JP 2017113010-A/4262: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA734222 - JP 2017140048-A/3092: TERMINALLY MODIFIED RNA.
LQ970603 - Sequence 13 from Patent EP2800820.
MA625397 - JP 2018138044-A/3: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
MA803391 - JP 2018183181-A/4262: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MB021438 - JP 2019050772-A/9: A test method for predicting side reactions after vaccination.
LY616597 - KR 1020180129785-A/494: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616333 - KR 1020180129785-A/230: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_031576
UCSC ID: uc021tgs.1
RefSeq Accession: NR_031576

-  Gene Model Information
 
category: antisense nonsense-mediated-decay: no RNA accession: NR_031576.1
exon count: 1CDS single in 3' UTR: no RNA size: 83
ORF size: 0CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 234.00frame shift in genome: no % Coverage: 100.00
has start codon: no stop codon in genome: no # of Alignments: 1
has end codon: no retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.